GLP-1 receptor agonist users were 1.36 times more likely to develop acne 90 days after starting the medication vs. nonusers. Women were 53% more likely to develop acne vulgaris 1 year after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results